Connect with us


In the weeds – The Martha’s Vineyard Times



Some people hand out lavender oil. Others can brew chamomile or valerian root tea. For me, cannabis is my ticket to a deep sleep.

I think I can say that here.

Nine years after being legalized in Massachusetts, the cannabis industry has not yet fully arrived on Martha’s Vineyard. But after a unique series of obstacles, mostly overcome by Geoff Rose, it seems to be coming soon (and possibly within weeks). We felt it made sense to offer this introduction to the facility, its benefits and the state of the business introduction. And because cannabis is still illegal at the federal level and the winery is only accessible by federal water and air, this community is literally and figuratively on an island for the twists and turns of the burgeoning industry.

So let’s talk about it. If you are over 21 years old, the legal age for consumption in Massachusetts, there really is nothing that should be shameful or stigmatized about using the plant – be it for something specific like sleep or just because you are the species and like the way you feel.

Cannabis can relieve all kinds of ailments: it can help with chronic pain; can serve as a muscle relaxant; can stimulate the appetite; Reduce inflammation; Treat seizures, insomnia, addiction; and help relieve depression and anxiety. Why? Due to cannabinoids – THC, CBD, etc – which, when activated by heating, vaporizing, smoking, cooking, trigger a reaction in which the cannabinoid compounds bind to receptors that are already in our body and the many Unlock the benefits of the plant.

Depending on the strain (there are more than 1,000), its subspecies (indica, sativa, or ruderalis), and your selection of cannabinoids (there are more than 100), each plant has its own unique composition. In addition, there are many different types of consumption (inhalation, ingestion, tinctures, oils), with each method having its own particular effects. You can tailor your cannabis experience to the therapy or non-therapy you are striving for.

Massachusetts voters reached a consensus on cannabis in 2012 and legalized the plant for medicinal use and then for recreational or adult use in 2016. Voters pulled the plant out of the depths of its historically stigmatized, illegal “underground” – The market. and maintained its place as an everyday commodity that people can buy, give away, grow and enjoy.

More than 200 medical and recreational pharmacies have opened in Massachusetts since legalization. It’s a booming business, and last month the Cannabis Control Commission reported that recreational stores have sold more than $ 1.5 billion worth of cannabis products since their debut in 2018.

If you ever set foot in any of these stores, you know it is a highly regulated experience. You will often have to make an appointment in advance and present some form of ID in a “waiting room” entrance. They are enthusiastic and are usually matched with a staff member or “budtender” who will guide you through the products available and help you find the right product.

If this is the experience you’re looking for here on Martha’s Vineyard, we’re not quite there, but we’re approaching and the finish line is in sight. Of course, there have been mixed reactions to an industry like this taking root on an island like this. And like many other communities, the winery can withstand change. But at the end of the day, business is business. And when it comes to cannabis, not only are there economic benefits to the island community (cities can receive up to 3 percent tax on adult purchases), but also additional labor, and – remember, since this stuff is medicine – access to one another health option.

If you followed this act at all, you know it was whiplash. But with all the uncertainties, there was one constant – and that constant is Geoff Rose.

The cannabis store that could

When marijuana was legalized for medicinal use in 2012, Rose was the guy who first saw a place for the industry on Martha’s Vineyard. He founded an LLC, Patient Centric of Martha’s Vineyard, with an overarching mission to “enable the island community to use cannabis safely and responsibly.”

The business is divided into three components: the medical / recreational pharmacy at 510 State Road in West Tisbury; the cultivation, processing and testing area in the Dr. Fisher Road 90 in West Tisbury; and the leisure shop at 15 Mechanic St. in Vineyard Haven. We’re in a unique position here on Martha’s Vineyard (and on Nantucket) because the plant is still federally illegal and cannot be shipped by federal water or air. That means all cultivation and product testing must be confined to the island, which meant Rose had to build a acreage and he had to build a testing site. Rose faced a series of “firsts” that no other cannabis entrepreneur in the state has seen (except possibly on Nantucket).

Rose refers to this store as his 8½ year old, and while it is still out of business as of mid-June for this issue, we can confidently say it is on the way. He took part in the meetings of the Selectmen and Zoning Board. He answered Abuttern. He cemented the agreements between the host and the community. He passed inspections. He even pushed, with the help of state representatives Julian Cyr and Dylan Fernandes, for a constitution to be passed so that product tests could be carried out on the island.

One step closer, one step closer, just a few more steps … and in March 2021 Rose threw us a curveball. To the surprise of many, Rose decided to sell the parts of his West Tisbury business.

In what he calls a “hybrid agreement,” Rose continues to retain ownership of the Vineyard Haven pharmacy, he said, but is moving the West Tisbury pharmacy and processing / growing location to a Connecticut-based family business called Fine Fat.

“They share the same mindset and philosophy as I do,” said Rose. “I thought it made sense for all parties.”

Fine Fettle owns and operates three medical marijuana dispensaries in Connecticut, an adult dispensary and an outdoor grow facility in Massachusetts, and a processing facility in Rhode Island. Before working in the marijuana space, the family business had been active in addiction aid and philanthropy for three generations. It expanded into the cannabis industry to build on that mission.

“We always think about [cannabis] from a health and wellbeing perspective, ”said CEO Benjamin Zachs, adding that the company is primarily“ committed to partnership with the community ”.

“We got it,” said Zachs. “There are concerns about traffic, smell, the changing structure of a local community. We are very aware of this. “

Rose and Zachs were introduced by a mutual friend around this time last year. After talking to them, Zachs said he was intrigued by the idea of ​​running a business in a seasonal location like the Vineyard.

“The more I talked to Geoff, the more I liked Geoff, and when we came to visit, we saw that he had built a really great facility,” Zachs said. “And that’s a big deal when you get something across the finish line to start the race.”

Rose said the sale was both financially driven and to “ease operational responsibilities.” He said he plans to work closely with Fine Fettle and will buy wholesale products from them.

I asked Rose and Zachs what they thought of some of the community rejections that came up after it was learned that part of the business had been sold to a company outside the island.

Rose played it outright: “I don’t listen to criticism from the community for selling the business.”

“You know, I’ve read some comments,” Zachs said. “People say, ‘This big company is coming.’ And I ask myself, ‘Are we the big companies that people are talking about?’ “

Fine Fettle employs around 75 people in three states, 68 of them in the pharmacies and growing areas. Zachs expects that there will be seven to twelve year-round full-time jobs in cultivation and six to eight year-round full-time jobs in the pharmacy on the island. He expects to create a little more staff for traffic handling in the summer months. Zachs said he intends to hire as locally as possible and plans to keep all or as many of Rose’s existing staff on board as he wishes.

Massachusetts has strict rules on the number of pharmacies an operator can manage: one company can only control three. Since Fine Fettle now has two – in West Tisbury and Rowley – it can still open another anywhere in the state, and Zachs said he was planning to. “We just haven’t figured out where yet,” he said.

And while opening such a company on Martha’s Vineyard presents operational challenges, Zachs seems to be focused on the positives.

“There can be a backlog when testing on the mainland. But because our tests are done on site and our pharmacy is there [a few miles] on the street we can possibly have the freshest product available, ”said Zachs. “I’m very happy that we can develop products that people like to visit.”

As for the opening, the Cannabis Control Commission recently approved the change of ownership from Rose to Zachs. Now Fine Fettle has to plan and pass a subsequent license test. Zachs hopes the medical pharmacy will be open for business by June and that recreational sales will go live by the end of July. “There are still a few CCC elements that we need to finish,” said Zachs.

For Rose and the Vineyard Haven Dispensary, which he said will be called Island Time, there is hope that the store will be operational by the first week of August as it will also need to pass additional inspections and CCC clearances.

Looking back over the last nearly ten years watching his child grow up, Rose said he was proud. “As time goes on, you will be dealt certain cards and you need to realize that you have local and state influences – you just have to keep rethinking how you are going,” said Rose. “It wasn’t a straight line, but I’m very happy with what I’ve achieved.”

“It’s my baby,” he said of the business, “and I’ve found great parents to take it forward.”

He gave the trip some superlatives: “It was the most exciting, scary, frustrating and amazing experience in my life.”

And it’s just beginning.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Medical Cannabis Market Size to Reach 47.15 Billion in 2027



VANCOUVER, BC, July 26, 2021 / PRNewswire / – The medical cannabis market is expected to reach global size $ 47.15 billion in 2027 at a CAGR of 16.9%, according to the latest report from Emergen Research. The growth in market revenue can be attributed to the increasing use of medical cannabis to treat diseases and conditions, increasing research and development activities, and the legalization of cannabis in various countries around the world. Increasing government initiatives to promote the safe use and consumption of the product are also a key factor that is expected to contribute to the market growth over the forecast period.

Medical cannabis is cannabis and cannabinoids that are prescribed by doctors and health professionals to relieve symptoms or treat illness. Preliminary studies suggest that cannabis may reduce nausea and vomiting, which are primary side effects of chemotherapy, improve appetite in people with HIV / AIDS, and relieve chronic pain and muscle spasms. Medicinal cannabis can be administered through capsules, tinctures, skin patches, and cannabis edibles, among other things. The increasing incidence of serious and chronic diseases such as cancer, Parkinson’s, Alzheimer’s and ALS, among other things, has encouraged the use of medicinal cannabis and led to the development of new products. In addition, cannabinoids are increasingly recommended for the treatment of anorexia, arthritis, migraines, and glaucoma when other treatment regimens are ineffective. This is expected to further spur the market’s revenue growth over the forecast period.

Click here to access a free sample PDF copy of the of [email protected]

Increasing research and development to study the medical uses of cannabis and the availability of synthetic cannabinoids as prescription drugs are some other key factors that are expected to contribute to future sales growth of the market. However, the lack of data on the long-term safety of medical cannabis, chronic side effects such as fatigue, dizziness and hallucinations, and the implementation of strict regulatory guidelines for the cultivation and marketing of cannabis are some key factors that are expected to continue to slow market growth .

Some key highlights in the report:

  • Oil segment sales are expected to grow at a CAGR of 17.5% over the forecast period due to increasing demand for hemp oil for clinical purposes such as reducing depression and anxiety, and relieving cancer symptoms and related pain.
  • The chronic pain segment is expected to account for the largest share of sales over the forecast period, as medicinal cannabis is primarily used to treat chronic pain and involuntary muscle spasms. Cannabis is used to treat chronic pain associated with many diseases and conditions, including multiple sclerosis, nerve pain, Parkinson’s, and PTSD, among others.
  • The inhalation segment dominated other routes of administration in terms of sales share in the global market in 2019, due to the fact that inhalation is the most common route of administration. Advances in product development have led to the introduction of various types of inhalers to make it easier for patients to consume medicinal cannabis.
  • North America is expected to account for the largest share of sales in the world market between 2020 and 2027, as recreational and medicinal cannabis is legalized, the number of product launches increases, investments to accelerate research and development for medical cannabis increase, and the strong presence of key players and Manufacturers in the region.
  • Major companies in the market include Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., Vivo Cannabis, Tikun Olam, and Insys Therapeutics, Inc.
  • In July 2021, the Medical Cannabis Commission has 6 companies in. Medical marijuana licenses granted Georgia, United Statesto grow marijuana under government supervision, convert it into CBD oil and sell the products to eligible patients in. market Georgia.
  • In July 2021, the first medical marijuana app of its kind, EcoCaNN, developed by the international pharmaceutical company MediCane, was launched in. brought on the market Israel which will enable medical cannabis patients to consult and communicate with doctors who specialize in the field. MediCane focuses on the research and development of cannabis-based drugs.

Make a Payment [Buy your Exclusive copy]@

For the purposes of this report, Emergen Research has segmented the global medical cannabis market by product type, application and route of administration, distribution channel, and region:

Product Type Outlook (Revenue, $ Billion; 2017-2027)

Application Outlook (Revenue, $ Billion; 2017-2027)

  • Chronic pain
  • Mental disorders
  • anorexia
  • Seizures
  • Muscle cramp
  • cancer
  • Other

Administrative Outlook Route (Revenue, $ Billion; 2017-2027)

  • Orally
  • Intravenously
  • inhalation
  • Currently

Sales Channel Outlook (Revenue, $ Billion; 2017-2027)

Check out the report description and table of contents of the market [email protected]

Regional Outlook (Revenue, Billion USD; 2017-2027)

  • North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • the rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
  • middle East & Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of MEA

Discover more reports from Emergen Research:

Cannabis market by product type (flower, concentrates, other), by compound (tetrahydrocannabinol, cannabidiol (CBD), balanced THC and CBD), by application (medicine, leisure, pain therapy, neurological health management, other) and regional forecasts for 2027

Drug Infusion Systems Market By Control Systems (Open Loop System, Closed Loop System), By Infusion Type (Continuous Infusion, Intermittent Infusion, Patient-Controlled Infusion, Total Parenteral Nutrition), By Route Of Administration, By Application, By End Use, And By Region Forecast To 2028

Compound Management Market by Solution (products and outsourcing services), by sample type (chemical compounds, biosamples), by application (drug research, gene synthesis, biobanking, others), by end-use (biopharmaceutical company, pharmaceutical company, biobank, CRO), and by region forecast by 2028

Nanotechnology market size, share, trends, by type (nanomaterials, nanocomposites, nano devices, nano tools), by industry (food and agriculture, health care, information and technology, environment, energy, cosmetics), and by region, forecast to 2028

In Vitro Fertilization: Overcoming Insurmountable Barriers to Infertility

Joint Reconstruction Devices: Addressing the Need for Long-Term Relief from Orthopedic Disease

Liquid Biopsy: A Revolution in Medical Oncology

About Emergen Research

Emergen Research is a market research and advisory firm that provides syndicated research reports, bespoke research reports, and advisory services. Our solutions focus solely on their purpose of locating, deliberately analyzing and analyzing changes in consumer behavior in various demographics and industries, and helping customers make smarter business decisions. We offer market research studies that ensure relevant and fact-based research across multiple industries including Healthcare, Touch Points, Chemicals, Types, and Energy. We constantly update our research offerings to ensure that our customers are informed about the latest trends in the market. Emergen Research has a strong base of experienced analysts from various specialist areas. Our industry experience and the ability to develop a specific solution for all research problems offer our customers the opportunity to secure a lead over their respective competitors.

Contact us:

Eric Lee
Sales specialist for companies
Emergeny research | Internet:
Direct line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkedIn | Twitter | Blogs
Read full press [email protected]

SOURCE Emergence Research

Continue Reading


CBD Topicals Benefits and Uses, and Most Common Types Available



We take a look at CBD topicals and discuss their benefits and uses. We also look at the most common types of topicals, including creams, lotions, balms, patches, and oils, and how to use them.

Advances in the medical and recreational cannabis market have resulted in the launch of a wide variety of products. The effects of CBD on humans have been studied and found to be very beneficial in some aspects. Due to the combination of market growth and positive effects, many new types of CBD products have been launched. Some of these are known as topical agents, which are products that you don’t have to ingest, but that you have to apply to the skin in some way to get the desired effect.

Why use CBD topicals?

Before we talk about why someone should use CBD topicals, let’s take a quick look at what they are. A CBD topical is essentially a product that can be applied to the skin. Like a cream or lotion fortified with cannabidiol. Whether it’s cannabis patches or some kind of lotion, topicals can be very helpful in some situations. These topical agents are widely used for their anti-inflammatory properties and other skin health benefits.

Much research has been done on the use of such products. It has been suggested that CBD has some anti-inflammatory properties. This allows CBD topicals to alleviate certain skin problems and joint pain to some extent. There are other ways these products can help as well, which is why they are so popular these days.

Types of CBD Topicals

As mentioned earlier, there are different types of themes in the market today. Before using any cannabis product, it is helpful to go through some dosage guidelines so that you know exactly how to use cannabis in various forms. Now let’s go over some common topics that you can get today:

CBD cream

Perhaps the most common type of topical on the market is a CBD cream. Many CBD skin creams use broad spectrum cannabidiol. This type of cannabidiol contains no or very small amounts of THC. Research has found that such a cream can provide relief for some conditions, such as:

– arthritis; as found in this study on rats in 2016.

– Peripheral neuropathy; as noted in this 2020 study.

– jaw pain; as found in this 2019 study.

Aside from its benefits, cannabidiol cream is one of the easiest products to use in this category. All you have to do is apply it directly to the affected area like a regular cream and it can provide quick relief. Sometimes such a product can also help users get some sleep.

Benefits and uses of CBD topicals and the most common types available

CBD patch

This is another type of product that is great for those who want to get the benefits of cannabidiol without smoking anything. Cannabis patches can be applied to the affected part of the body and the effect can be felt in 5-15 minutes. These patches are great for quick pain relief and also have the anti-inflammatory properties of cannabidiol.

This is a very good method of delivering cannabidiol to the body for beginners as there isn’t much to do. They’re not very expensive either. And their effects are easy to control, as you can easily take them off if you feel overwhelmed in any way.

CBD lotion

Just like creams, CBD lotion can be applied directly to the skin. There are many strains available for people who want the benefits of cannabidiol along with those of a healthy skin lotion at the same time. The lotions are great for making the skin healthier and restoring damaged skin.

Think of a cannabidiol fortified lotion as your regular, moisturizing lotion, but with added benefits like reducing inflammation, soothing the skin, fighting dryness, and reducing dark spots and wrinkles.

Benefits and uses of CBD topicals and the most common types available

CBD balm

Balms are another great option for people looking for pain relieving and anti-inflammatory effects. These can be used on any part of the body that you experience pain and suffering. Like creams, balms provide fairly quick relief and require nothing more than to rub them into the skin.

CBD oil and butter

There are many other forms of cannabidiol topicals, two of which are oil and butter. There are different types of oil and butter, but as for the topicals. Both products are used directly on the skin. For example, there are facial oils that can be dabbed around the eyes to reduce wrinkles or applied to the face for other benefits. There are also products like lip butters that can be applied to the lips for moisture and smoothness.


Whether you are looking for a topical agent for pain relief or recreational purposes, there are many choices. This wide variety of products is perfect for those who are new to cannabis and don’t want to smoke it, but still want to benefit from its effects.

All you have to do is apply such a product directly to the skin and wait a while. They are easier to control in their dosage and are not as potent as smoking marijuana. Make them more accessible to all types of users.

Continue Reading


Tauriga Sciences Inc. Generates Record Daily E-Commerce Revenue for Sunday, July 25, 2021




TAURI soap product line (6 SKUs / 6 fragrances)

TAURI soap product line (6 SKUs / 6 fragrances)

The company generated more than $ 13,000.00 in e-commerce sales for the date: July 25, 2021

NEW YORK, NY, July 26, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a diversified life sciences company headquartered in New York, today announced that it has set a new one-day (“Daily”) e-commerce sales record for Sunday, July 25th, 2021. The company had more than $ 13,000 in e-commerce sales, or nearly 200 individual transactions, on July 25, 2021.

This “daily” e-commerce sales record was driven by the latest additions to product inventory, including: 1) TAURI soap and candle product lines (6 fragrances: pomegranate, blood orange, peach-lemon, pear bellini, mint and blackcurrant), 2) Delta 8 THC (25 mg) + Melatonin (5 mg) Infused Gummy Bears with Wild Blueberry Flavor, 3) CBD Isolate (25 mg) Infused Gummy Bears with Blue Raspberry / Strawberry Flavor, 4) TAURI Tropical Topical Body Butter Infused with CBD oil (120 mg.)), 5) TAURI coconut milk chocolate squares, enriched with full-spectrum CBD (“hemp”) extract (25 mg), 6) TAURI-Diabetic Friendly full-spectrum CBD (“hemp”) – Enriched Extract (25 mg) + Immunity Boost & Melatonin Lavender Chocolate Squares, 7) Tauri-Sun ™ 30 SPF CBD Isolate Infused (200 mg) Sunscreen Spray and 8) Tauri-Sun ™ 30 SPF CBD Infused Acai Fragrance Moisturizing Lip Balm .

Please visit the company’s e-commerce website:


The company fully anticipates the arrival of inventory for its upgraded Tauri-Gum ™ product line (9 SKUs + 2 Limited Edition SKUs) later this week. Upon receipt, the company will fulfill its Tauri-Gum ™ pre-orders and meet with buyers from a wide range of potential retail customers. In addition, the company is confident that its e-commerce business will benefit significantly from the availability of its flagship brand, Tauri-Gum ™.


The story goes on

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life science company that is involved in several key business activities and initiatives. The company manufactures and sells several proprietary retail products and product lines primarily focused on the cannabidiol (“CBD”) and cannabigerol (“CBG”) edibles market segments. The main Tauri-Gum ™ branded product line consists of a proprietary dietary supplement chewing gum that is Kosher Certified, Halal Certified and Vegan Formulated (CBD Infused Tauri-Gum ™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused.) Tauri-Gum ™ flavors: peach-lemon, blackcurrant), (Tauri-Gum ™ flavor enriched with vitamin C + zinc: Bellini pear), (Tauri-Gum ™ flavor enriched with caffeine: Cherry Lime Rickey) & (vitamin D3 enriched Tauri -Gum ™ Flavor: Golden Raspberry). The company’s commercialization strategy consists of a wide range of retail customers, distributors and a rapidly growing e-commerce business segment (e-commerce website: Further information and inquiries can be found on our company website at

Complementary to the company’s retail business is its ongoing pharmaceutical development initiative. This relates to the development of a proposed pharmaceutical version of Tauri-Gum ™ for the control of nausea (specifically designed for the following indication: patients undergoing ongoing chemotherapy). On March 22, 2021, the company announced that it had converted its U.S. provisional patent application (filed March 17, 2020) into a U.S. non-provisional patent application. The patent filed with the USPTO is entitled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020, the company announced that it had entered into a master services agreement with CSTI to lead the company’s clinical development efforts.

The company is headquartered in Wappingers Falls, New York. The company also operates two full-time e-commerce fulfillment centers: one in Montgomery, Texas and the other in Brooklyn, New York.

DISCLAIMER – Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect management’s beliefs and beliefs about future events. These forward-looking statements are often identified by the use of words such as “may,” “will,” “expects,” “expects,” believes, “hopes,” “believes,” or plans and may include statements about company goals such as z and the achievement of certain company goals and milestones. Forward-looking statements are based on current circumstances and management’s current views with respect to events that did not occur, that may not occur, or that may have different consequences or timing than now believed or expected. Actual results could differ materially from known and unknown risks and uncertainties from those expressed in forward-looking statements upon successful acquisition and licensing transactions, currency fluctuations and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are further discussed in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings that may be filed with the Securities and Exchange Commission from time to time. Such forward-looking statements are made only as of this date and Tauriga assumes no obligation to update any forward-looking statements to reflect future events or circumstances. You should not place undue reliance on these forward-looking statements.


Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Managing Director

Mr. Seth M. Shaw


Cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram: @ sethsms47

Twitter: @SethMShaw

Corp. Website:

E-commerce website:


Continue Reading